{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25893199", "DateCompleted": {"Year": "2016", "Month": "01", "Day": "08"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "03", "Day": "17"}], "ELocationID": ["971982", "10.1155/2015/971982"], "Language": ["eng"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2015", "PubDate": {"Year": "2015"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation.", "Pagination": {"StartPage": "971982", "MedlinePgn": "971982"}, "Abstract": {"AbstractText": ["Ayurvedic plants are known for thousands of years to have anti-inflammatory and antiarthritic effect. We have recently shown that BV-9238, a proprietary formulation of Withania somnifera, Boswellia serrata, Zingiber officinale, and Curcuma longa, inhibits LPS-induced TNF-alpha and nitric oxide production from mouse macrophage and reduces inflammation in different animal models. To evaluate the safety parameters of BV-9238, we conducted a cytotoxicity study in RAW 264.7 cells (0.005-1 mg/mL) by MTT/formazan method, an acute single dose (2-10 g/kg bodyweight) toxicity study and a 180-day chronic study with 1 g and 2 g/kg bodyweight in Sprague Dawley rats. Some sedation, ptosis, and ataxia were observed for first 15-20 min in very high acute doses and hence not used for further chronic studies. At the end of 180 days, gross and histopathology, blood cell counts, liver and renal functions were all at normal levels. Further, a modest attempt was made to assess the effects of BV-9238 (0.5 \u00b5g/mL) on six major human cytochrome P450 enzymes and (3)H radioligand binding assay with human hERG receptors. BV-9238 did not show any significant inhibition of these enzymes at the tested dose. All these suggest that BV-9238 has potential as a safe and well tolerated anti-inflammatory formulation for future use."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioved Pharmaceuticals Pvt. Ltd., BAIF Bhawan, Z Wing, Warje Malwadi, Pune 411 052, India."}], "LastName": "Dey", "ForeName": "Debendranath", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioved Pharmaceuticals Pvt. Ltd., BAIF Bhawan, Z Wing, Warje Malwadi, Pune 411 052, India."}], "LastName": "Chaskar", "ForeName": "Sunetra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioved Pharmaceuticals Pvt. Ltd., BAIF Bhawan, Z Wing, Warje Malwadi, Pune 411 052, India."}], "LastName": "Athavale", "ForeName": "Nitin", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioved Pharmaceuticals, Inc., 1929 O'Toole Way, San Jose, CA 95131, USA."}], "LastName": "Chitre", "ForeName": "Deepa", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "ERG1 Potassium Channel"}, {"RegistryNumber": "0", "NameOfSubstance": "Ether-A-Go-Go Potassium Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "KCNH2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cytochrome P-450 Enzyme Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": [], "DescriptorName": "ERG1 Potassium Channel"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Ether-A-Go-Go Potassium Channels"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["toxicity"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vora C. K., Mansoor G. A. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Current Hypertension Reports. 2005;7(4):275\u2013280. doi: 10.1007/s11906-005-0025-0.", "ArticleIdList": ["10.1007/s11906-005-0025-0", "16061046"]}, {"Citation": "Schoepfer A. M., Engel A., Fattinger K., et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. Journal of Hepatology. 2007;47(4):521\u2013526. doi: 10.1016/j.jhep.2007.06.014.", "ArticleIdList": ["10.1016/j.jhep.2007.06.014", "17692989"]}, {"Citation": "Michalsen A. The role of complementary and alternative medicine (CAM) in rheumatology\u2014it's time for integrative medicine. The Journal of Rheumatology. 2013;40(5):547\u2013549. doi: 10.3899/jrheum.130107.", "ArticleIdList": ["10.3899/jrheum.130107", "23637376"]}, {"Citation": "Firenzuoli F., Gori L. Herbal medicine today: clinical and research issues. Evidence-Based Complementary and Alternative Medicine. 2007;4(supplement 1):37\u201340. doi: 10.1093/ecam/nem096.", "ArticleIdList": ["10.1093/ecam/nem096", "PMC2206236", "18227931"]}, {"Citation": "Cohen P. A. Hazards of hindsight\u2014monitoring the safety of nutritional supplements. The New England Journal of Medicine. 2014;370(14):1277\u20131280. doi: 10.1056/nejmp1315559.", "ArticleIdList": ["10.1056/nejmp1315559", "24693886"]}, {"Citation": "Lahlou S., Israili Z. H., Lyoussi B. Acute and chronic toxicity of a lyophilised aqueous extract of Tanacetum vulgare leaves in rodents. Journal of Ethnopharmacology. 2008;117(2):221\u2013227. doi: 10.1016/j.jep.2008.01.024.", "ArticleIdList": ["10.1016/j.jep.2008.01.024", "18378415"]}, {"Citation": "Ha H., Lee J. K., Lee H. Y., et al. Evaluation of safety of the herbal formula Ojeok-san: acute and sub-chronic toxicity studies in rats. Journal of Ethnopharmacology. 2010;131(2):410\u2013416. doi: 10.1016/j.jep.2010.07.011.", "ArticleIdList": ["10.1016/j.jep.2010.07.011", "20633626"]}, {"Citation": "Wanga M., Liub J., Zhoub B., et al. Acute and sub-chronic toxicity studies of Danshen injection in Sprague-Dawley rats. Journal of Ethnopharmacology. 2012;141(1):96\u2013103. doi: 10.1016/j.jep.2012.02.005.", "ArticleIdList": ["10.1016/j.jep.2012.02.005", "22343168"]}, {"Citation": "Scartezzini P., Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. Journal of Ethnopharmacology. 2000;71(1-2):23\u201343. doi: 10.1016/S0378-8741(00)00213-0.", "ArticleIdList": ["10.1016/S0378-8741(00)00213-0", "10904144"]}, {"Citation": "Thabrew M. I., Senaratna L., Samarawickrema N., Munasinghe C. Antioxidant potential of two polyherbal. Preparations used in Ayurveda for the treatment of rheumatoid arthritis. Journal of Ethnopharmacology. 2001;76(3):285\u2013291. doi: 10.1016/s0378-8741(01)00213-6.", "ArticleIdList": ["10.1016/s0378-8741(01)00213-6", "11448551"]}, {"Citation": "Chopra A., Patil J., Doiphode V., Patwardhan B. Exploring ancient Ayurveda for rheumatology; traditional therapy, modern relevance and challenges. APLAR Journal of Rheumatology. 2001;4:190\u2013199."}, {"Citation": "Dugasani S., Pichika M. R., Nadarajah V. D., Balijepalli M. K., Tandra S., Korlakunta J. N. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. Journal of Ethnopharmacology. 2010;127(2):515\u2013520. doi: 10.1016/j.jep.2009.10.004.", "ArticleIdList": ["10.1016/j.jep.2009.10.004", "19833188"]}, {"Citation": "Chopra A., Lavin P., Patwardhan B., Chitre D. Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. Journal of Rheumatology. 2000;27(6):1365\u20131372.", "ArticleIdList": ["10852255"]}, {"Citation": "Chopra A., Lavin P., Patwardhan B., Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. Journal of Clinical Rheumatology. 2004;10(5):236\u2013245. doi: 10.1097/01.rhu.0000138087.47382.6d.", "ArticleIdList": ["10.1097/01.rhu.0000138087.47382.6d", "17043520"]}, {"Citation": "Dey D., Chaskar S., Athavale N., Chitre D. Inhibition of LPS-Induced TNF-\u03b1 and NO production in mouse macrophage and inflammatory response in rat animal models by a novel ayurvedic formulation, BV-9238. Phytotherapy Research. 2014;28(10):1479\u20131485. doi: 10.1002/ptr.5151.", "ArticleIdList": ["10.1002/ptr.5151", "24706581"]}, {"Citation": "Bongartz T. I., Sutton A. J., Sweeting M. J., Buchan I., Matteson E. L., Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. The Journal of the American Medical Association. 2006;295(19):2275\u20132285.", "ArticleIdList": ["16705109"]}, {"Citation": "Bernatsky S., Feldman D., De Civita M., et al. Optimal care for rheumatoid arthritis: a focus group study. Clinical Rheumatology. 2010;29(6):645\u2013657. doi: 10.1007/s10067-010-1383-9.", "ArticleIdList": ["10.1007/s10067-010-1383-9", "20127397"]}, {"Citation": "Obach R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics. 2000;294(1):88\u201395.", "ArticleIdList": ["10871299"]}, {"Citation": "Tang C., Shou M., Mei Q., Rushmore T. H., Rodrigues A. D. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. Journal of Pharmacology and Experimental Therapeutics. 2000;293(2):453\u2013459.", "ArticleIdList": ["10773015"]}, {"Citation": "Delgoda R., Westlake A. C. G. Herbal interactions involving cytochrome P450 enzymes. Toxicological Reviews. 2004;23(4):239\u2013249. doi: 10.2165/00139709-200423040-00004.", "ArticleIdList": ["10.2165/00139709-200423040-00004", "15898829"]}, {"Citation": "Zhou S., Gao Y., Jiang W., Huang M., Xu A., Paxton J. W. Interactions of herbs with cytochrome P450. Drug Metabolism Reviews. 2003;35(1):35\u201398.", "ArticleIdList": ["12635815"]}, {"Citation": "Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Neurology. 2014;4, article 177 doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Pratt C. M., Al-Khalidi H. R., Brum J. M., et al. Cumulative experience of azimilide associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database. Journal of the American College of Cardiology. 2006;48(3):471\u2013477. doi: 10.1016/j.jacc.2006.04.075.", "ArticleIdList": ["10.1016/j.jacc.2006.04.075", "16875971"]}, {"Citation": "Darpo B. Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes. European Heart Journal. 2001;3:70\u201380."}, {"Citation": "Justo D., Prokhorov V., Heller K., Zeltser D. Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors. Acta Psychiatrica Scandinavica. 2005;111(3):171\u2013176. doi: 10.1111/j.1600-0447.2004.00469.x.", "ArticleIdList": ["10.1111/j.1600-0447.2004.00469.x", "15701100"]}, {"Citation": "Sanguinetti M. C., Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440(7083):463\u2013469. doi: 10.1038/nature04710.", "ArticleIdList": ["10.1038/nature04710", "16554806"]}, {"Citation": "Chitre D., Dey D. Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases. US Patent Application Publication. 2010;(2010/0150865 A1)"}, {"Citation": "Chan P. K., O'Hara G. P., Hayes A. W. Principles and methods for acute and subchronic toxicity. In: Hayes A. W., editor. Principles and Methods of Toxicology. New York, NY, USA: Raven Press; 1982. pp. 17\u201319."}, {"Citation": "Feldman B. F., Zinkl J. G., Jain N. C., Moor D. M. Schalm's Veterinary Hematology. 5th. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2000."}, {"Citation": "Crespi C. L., Miller V. P., Penman B. W. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Analytical Biochemistry. 1997;248(1):188\u2013190. doi: 10.1006/abio.1997.2145.", "ArticleIdList": ["10.1006/abio.1997.2145", "9177742"]}, {"Citation": "Marks B. D., Smith R. W., Braun H. A., et al. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate. ASSAY and Drug Development Technologies. 2002;1(1):73\u201381. doi: 10.1089/154065802761001329.", "ArticleIdList": ["10.1089/154065802761001329", "15090158"]}, {"Citation": "Zhou Z., Gong Q., Ye B., et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophysical Journal. 1998;74(1):230\u2013241. doi: 10.1016/S0006-3495(98)77782-3.", "ArticleIdList": ["10.1016/S0006-3495(98)77782-3", "PMC1299377", "9449325"]}, {"Citation": "Finlayson K., Turnbull L., January C. T., Sharkey J., Kelly J. S. [3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. European Journal of Pharmacology. 2001;430(1):147\u2013148. doi: 10.1016/s0014-2999(01)01362-0.", "ArticleIdList": ["10.1016/s0014-2999(01)01362-0", "11698075"]}, {"Citation": "Chopra A., Saluja M., Tillu G., et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology. 2013;52(8):1408\u20131417. doi: 10.1093/rheumatology/kes414.ket414", "ArticleIdList": ["10.1093/rheumatology/kes414", "23365148"]}, {"Citation": "Soll A. H., Weinstein W. M., Kurata J., McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of Internal Medicine. 1991;114(4):307\u2013319. doi: 10.7326/0003-4819-114-4-307.", "ArticleIdList": ["10.7326/0003-4819-114-4-307", "1987878"]}, {"Citation": "Xie W., Robertson D. L., Simmons D. L. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Development Research. 1992;25(4):249\u2013265. doi: 10.1002/ddr.430250402.", "ArticleIdList": ["10.1002/ddr.430250402"]}, {"Citation": "Vane J. R. Towards a better aspirin. Nature. 1994;367(6460):215\u2013216. doi: 10.1038/367215a0.", "ArticleIdList": ["10.1038/367215a0", "8121485"]}, {"Citation": "Frolov R. V., Ignatova I. I., Singh S. Inhibition of hERG potassium channels by celecoxib and its mechanism. PLoS ONE. 2011;6(10) doi: 10.1371/journal.pone.0026344.e26344", "ArticleIdList": ["10.1371/journal.pone.0026344", "PMC3200315", "22039467"]}, {"Citation": "ICH Harmonized Tripartite Guideline E14. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. 2005.   http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf."}, {"Citation": "Mukkavilli R., Gundala S. R., Yang C., et al. Modulation of cytochome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics. PLoS ONE. 2014;9(9) doi: 10.1371/journal.pone.0108386.e108386", "ArticleIdList": ["10.1371/journal.pone.0108386", "PMC4177392", "25251219"]}, {"Citation": "Chen X.-W., Sneed K. B., Pan S.-Y., et al. Herb-drug interactions and mechanistic and clinical considerations. Current Drug Metabolism. 2012;13(5):640\u2013651. doi: 10.2174/1389200211209050640.", "ArticleIdList": ["10.2174/1389200211209050640", "22292789"]}, {"Citation": "Colombo D., Lunardon L., Bellia G. Cyclosporine and herbal supplement interactions. Journal of Toxicology. 2014;2014:6. doi: 10.1155/2014/145325.145325", "ArticleIdList": ["10.1155/2014/145325", "PMC3913293", "24527031"]}, {"Citation": "Li M., Chen P. Z., Yue Q. X., et al. Pungent ginger components modulates human cytochrome P450 enzymes in vitro. Acta Pharmacologica Sinica. 2013;34(9):1237\u20131242. doi: 10.1038/aps.2013.49.", "ArticleIdList": ["10.1038/aps.2013.49", "PMC4003154", "23770984"]}, {"Citation": "Frank A., Unger M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. Journal of Chromatography A. 2006;1112(1-2):255\u2013262. doi: 10.1016/j.chroma.2005.11.116.", "ArticleIdList": ["10.1016/j.chroma.2005.11.116", "16364338"]}, {"Citation": "Rahmani A. H., Al Zohairy M. A., Aly S. M., Khan M. A. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways. BioMed Research International. 2014;2014:15. doi: 10.1155/2014/761608.761608", "ArticleIdList": ["10.1155/2014/761608", "PMC4176907", "25295272"]}, {"Citation": "Gui H.-Y., Chen R.-N., Peng Y., et al. Curcumin protects against 1-methyl-4-phenylpyridinium ion- and lipopolysaccharide-induced cytotoxicities in the mouse mesencephalic astrocyte via inhibiting the cytochrome P450 2E1. Evidence-Based Complementary and Alternative Medicine. 2013;2013:13. doi: 10.1155/2013/523484.523484", "ArticleIdList": ["10.1155/2013/523484", "PMC3703411", "23843878"]}, {"Citation": "Pimkaew P., K\u00fcblbeck J., Petsalo A., et al. Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system. Toxicology in Vitro. 2013;27(6):2005\u20132012. doi: 10.1016/j.tiv.2013.07.004.", "ArticleIdList": ["10.1016/j.tiv.2013.07.004", "23850985"]}, {"Citation": "Savai J., Varghese A., Pandita N. Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV. Journal of Pharmaceutical Negative Results. 2013;4(1):26\u201332. doi: 10.4103/0976-9234.116766.", "ArticleIdList": ["10.4103/0976-9234.116766"]}, {"Citation": "Rana S., Lattoo S. K., Dhar N., et al. NADPH-cytochrome P450 reductase: molecular cloning and functional characterizationof two paralogs from Withania somnifera (L.) dunal. PLoS ONE. 2013;8(2) doi: 10.1371/journal.pone.0057068.e57068", "ArticleIdList": ["10.1371/journal.pone.0057068", "PMC3578826", "23437311"]}, {"Citation": "Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Annals of Internal Medicine. 1991;115(10):787\u2013796. doi: 10.7326/0003-4819-115-10-787.", "ArticleIdList": ["10.7326/0003-4819-115-10-787", "1834002"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "12", "Day": "16"}, {"Year": "2015", "Month": "2", "Day": "20"}, {"Year": "2015", "Month": "2", "Day": "20"}, {"Year": "2015", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "3", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["25893199", "PMC4381553", "10.1155/2015/971982"]}}], "PubmedBookArticle": []}